TH147031A - New dosing sizes and formulations - Google Patents
New dosing sizes and formulationsInfo
- Publication number
- TH147031A TH147031A TH901000973A TH0901000973A TH147031A TH 147031 A TH147031 A TH 147031A TH 901000973 A TH901000973 A TH 901000973A TH 0901000973 A TH0901000973 A TH 0901000973A TH 147031 A TH147031 A TH 147031A
- Authority
- TH
- Thailand
- Prior art keywords
- pharmaceutical
- bromide
- aclidnium
- dry powder
- equivalent
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 239000000843 powder Substances 0.000 claims abstract 5
- 239000000969 carrier Substances 0.000 claims abstract 3
- 150000003839 salts Chemical class 0.000 claims abstract 3
- 239000011780 sodium chloride Substances 0.000 claims abstract 3
- 241000983381 Adenium Species 0.000 claims abstract 2
- 208000006673 Asthma Diseases 0.000 claims abstract 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims abstract 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-O acridine;hydron Chemical compound C1=CC=CC2=CC3=CC=CC=C3[NH+]=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-O 0.000 claims abstract 2
- 201000010099 disease Diseases 0.000 claims abstract 2
- 239000005426 pharmaceutical component Substances 0.000 claims abstract 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims 3
- WOVFJBGKJQEQQD-UHFFFAOYSA-N acridine;hydrobromide Chemical compound [Br-].C1=CC=CC2=CC3=CC=CC=C3[NH+]=C21 WOVFJBGKJQEQQD-UHFFFAOYSA-N 0.000 claims 1
- 229960003154 clidinium Drugs 0.000 claims 1
- -1 clidinium bromides Chemical class 0.000 claims 1
- 239000000470 constituent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 239000008176 lyophilized powder Substances 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 229960005098 Clidinium bromide Drugs 0.000 abstract 1
- GKEGFOKQMZHVOW-KUTGSRRKSA-M clidinium bromide Chemical compound [Br-].C1([C@H]2CC[N@+](CC2)(C1)C)OC(=O)C(O)(C=1C=CC=CC=1)C1=CC=CC=C1 GKEGFOKQMZHVOW-KUTGSRRKSA-M 0.000 abstract 1
Abstract
DC60 องค์ประกอบทางเภสัชกรรมสำหรับการสูดดมที่ใช้สำหรับการบำบัดรักษาโรคของทางเดิน ลมหายใจ โดยเฉพาะโรคหอบหืด และโรคปอดอุดกั้นเรื้อรัง (Chronic obstructive pulmonary disease (COPD)) ซึ่งประกอบด้วยแอคลิดิเนียมในรูปของผงแห้งของเกลือที่เป็นที่ยอมรับ ทางเภสัชกรรมผสมกับตัวพาผงแห้งที่เป็นที่ยอมรับทางเภสัชกรรม ซึ่งให้แอคลิดิเนียมในขนาด การให้ตามที่วัดได้จริงเทียบเท่ากับแอคลิดิเนียมโบรไมด์ประมาณ 400 (มิว)g สิทธิบัตรยา DC60, pharmaceutical component for inhalation, used for the treatment of diseases of the airway, especially asthma. And Chronic obstructive pulmonary disease (COPD), which contains acridinium in the form of a dry powder of acceptable salt. Pharmaceutical mixes with a pharmaceutical dry powder carrier. Which gives the adenium in size The actual measurable giving is equivalent to approximately 400 (mu) g of clidinium bromide.
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH0901000973A TH0901000973A (en) | 2016-03-04 |
| TH147031A true TH147031A (en) | 2016-03-04 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2009000602A1 (en) | Inhalable dry powder pharmaceutical composition comprising aclidinium bromide and a carrier, providing a nominal metered dose of aclidinium equivalent to about 400 micrograms of aclidinium bromide; its use in COPD and asthma; multi-dose dry powder inhaler device. | |
| AR067639A1 (en) | PULVERULENT MEDICINES CONTAINING TIOTROPY AND SALMETROL, AS WELL AS LACTOSE AS EXCIPIENT | |
| CL2009000601A1 (en) | Inhalable pharmaceutical composition in dry powder form comprising aclidinium bromide and a carrier, providing a nominal metered dose of aclinium equivalent to approximately 200 ug of aclinium bromide; its use in COPD and asthma; multi-dose dry powder inhaler device. | |
| CY1120605T1 (en) | DRY POWDER PREPARATION INCLUDING A PHOSPHODIESTERATION INHIBITOR | |
| EA201401354A1 (en) | NEW DOSED FORM AND PREPARATION CONTAINING ABEDTEROL | |
| ECSP024268A (en) | NEW POWDER FOR INHALATION CONTAINING TIOTROPY | |
| HRP20050570A2 (en) | Powdered medicament for inhalation comprising a tiotropium salt and salmetrol xinafoate | |
| MEP30108A (en) | Formoterol superfine formulation | |
| EA201590030A1 (en) | DRY POWDER INHALERS, CONTAINING CARRIER, EXCELLENT FROM LACTOSE, AND THIRD COMPONENT | |
| WO2006008517A3 (en) | Use of dry powder compositions for pulmonary delivery | |
| NI201100066A (en) | INHALABLE PARTICLES INCLUDING THYOTROPE. | |
| EA201201397A1 (en) | INHALER CONTAINING DISTRIBUTED GLISTER PACKING | |
| EA201590019A1 (en) | DRY POWDER INHALERS, CARRIER CONTAINING, EXCELLENT FROM LACTOSE | |
| CL2014003211A1 (en) | Pharmaceutical composition for inhalation comprising aclidinium, with lactose, which provides a dose of 322 ug of free base and approx. 140 ug of aclidinium bromide; a method to treat a respiratory condition selected from asthma and epoc; use of the composition; and a calibrated dry powder inhaler device comprising it | |
| EA201201393A1 (en) | INHALER, DEVELOPED FOR DELIVERY OF MEDICINES AS DRY POWDER | |
| EA201201392A1 (en) | PUSH-BUTTON DEVICE | |
| UA115989C2 (en) | Dry powder inhaler compositions comprising long acting muscorinic antagonists | |
| EA201201389A1 (en) | INHALER, CREATING TURBULENCE | |
| TH147031A (en) | New dosing sizes and formulations | |
| MEP51608A (en) | Pulverulent formulation for inhalation containing tiotropium | |
| EA201201394A1 (en) | INHALER FOR DELIVERY OF MEDICINE IN THE FORM OF DRY POWDER | |
| TR200909788A2 (en) | Dry powder formulation suitable for inhalation with tiotropium | |
| TH1401007107A (en) | New form, dosage form and formulation formulation of AB Dieterol | |
| TR201004317A2 (en) | Inhalation device for turbulence. |